| |
|
|
| Name: |
Octagon Capital Advisors LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10065 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
9 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
DNTH |
Dianthus Therapeutics Ord Shs |
3 |
- |
$0.70 |
$41,420,000 |
1,380,667 |
5.04% |
35,658,000 |
826,667 |
9.316 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
5 |
- |
$31.22 |
$35,287,000 |
1,242,945 |
4.29% |
24,741,000 |
450,000 |
1.532 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
11 |
- |
$37.06 |
$21,713,000 |
506,604 |
2.64% |
4,838,000 |
92,604 |
1.092 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
20 |
- |
$48.30 |
$13,601,000 |
194,000 |
1.65% |
3,916,000 |
78,000 |
0.158 |
Biotechnology |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
27 |
- |
$0.00 |
$8,696,000 |
3,030,000 |
1.06% |
8,696,000 |
3,030,000 |
1.621 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
36 |
- |
$10.42 |
$5,005,000 |
1,374,870 |
0.61% |
3,495,000 |
374,870 |
0.635 |
N/A |
|
|
PHAT |
Phathom Pharmaceuticals, Inc. |
37 |
- |
$0.00 |
$4,832,000 |
455,000 |
0.59% |
4,375,000 |
405,000 |
0.795 |
N/A |
|
|
ANAB |
Anaptysbio Inc |
42 |
- |
$23.91 |
$3,716,000 |
165,000 |
0.45% |
1,146,000 |
45,000 |
0.519 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
44 |
- |
$2.02 |
$3,585,000 |
1,103,000 |
0.44% |
-10,032,000 |
438,425 |
3.709 |
N/A |
|
